United States of America

2020 Edition

Interviews
Janet Woodcock
Director, Center for Drug Evaluation and Research (CDER), US FDA

As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s heal…

Peter Marks
Director, Center for Biologics Evaluation and Research (CBER), US FDA

Dr Peter Marks MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), highlights the Center’s…

Janet Woodcock
Director, Center for Drug Evaluation and Research (CDER), US FDA

As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s heal…

Peter Marks
Director, Center for Biologics Evaluation and Research (CBER), US FDA

Dr Peter Marks MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), highlights the Center’s…

Ramona Sequeira
President, Takeda Pharmaceuticals USA; President, Global Portfolio Commercialization; Member of Takeda Global Executive Team

Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portf…

Barbara Lopez Kunz
CEO, Drug Information Association (DIA), USA

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory science, patient engagement, translational science, and…

Ramona Sequeira
President, Takeda Pharmaceuticals USA; President, Global Portfolio Commercialization; Member of Takeda Global Executive Team

Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portf…

Barbara Lopez Kunz
CEO, Drug Information Association (DIA), USA

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory science, patient engagement, translational science, and…

Read the Full Version
Bill Sibold
Executive Vice President, Sanofi Genzyme

Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth of potential break…

Ameet Mallik
EVP, Head of US, Novartis Oncology

Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company’s culture of ‘curious, inspired, and unbossed,’ how Novartis differentiates itself in a highly competitive oncolo…

Peter Anastasiou
Executive VP & Head of North America, Lundbeck

Industry veteran Peter Anastasiou, executive VP and head of North America for Danish CNS specialist Lundbeck, outlines the performance of Lundbeck’s specialty portfolio in…

Bill Sibold
Executive Vice President, Sanofi Genzyme

Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth of potential break…

Ameet Mallik
EVP, Head of US, Novartis Oncology

Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company’s culture of ‘curious, inspired, and unbossed,’ how Novartis differentiates itself in a highly competitive oncolo…

Peter Anastasiou
Executive VP & Head of North America, Lundbeck

Industry veteran Peter Anastasiou, executive VP and head of North America for Danish CNS specialist Lundbeck, outlines the performance of Lundbeck’s specialty portfolio in…

Tatsuya Kaihara
Corporate Officer, Head of North America Business, Santen Pharmaceutical Co., Ltd. & CEO, Santen Inc.

Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his…

Carol Lynch
President, Sandoz US; Head, Sandoz North America; Member of the Sandoz Executive Committee

Carol Lynch of Sandoz US talks candidly on the US generics market from an international perspective…

Peter L. Saltonstall
President & CEO, National Organization for Rare Disorders (NORD), USA

Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what…

Tatsuya Kaihara
Corporate Officer, Head of North America Business, Santen Pharmaceutical Co., Ltd. & CEO, Santen Inc.

Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his…

Carol Lynch
President, Sandoz US; Head, Sandoz North America; Member of the Sandoz Executive Committee

Carol Lynch of Sandoz US talks candidly on the US generics market from an international perspective…

Peter L. Saltonstall
President & CEO, National Organization for Rare Disorders (NORD), USA

Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what…

Ivan Cheung
Chairman, Eisai Inc.; President, Neurology Business Group, Eisai Co., Ltd.

Ivan Cheung, head of Japanese firm Eisai’s US operations, highlights the significance of a potential 2021 US…

Chip Davis
President & CEO, Association for Accessible Medicines (AAM), USA

The AAM’s Chip Davis gives an account of his agenda for 2020, how the association is driving policy in a…

Matt Eyles
President & CEO, Association of Healthcare Insurance Providers (AHIP), USA

Matt Eyles, president and CEO of the Association of Healthcare Insurance Providers (AHIP) outlines how the US health insurance landscape has…

Ivan Cheung
Chairman, Eisai Inc.; President, Neurology Business Group, Eisai Co., Ltd.

Ivan Cheung, head of Japanese firm Eisai’s US operations, highlights the significance of a potential 2021 US…

Chip Davis
President & CEO, Association for Accessible Medicines (AAM), USA

The AAM’s Chip Davis gives an account of his agenda for 2020, how the association is driving policy in a…

Matt Eyles
President & CEO, Association of Healthcare Insurance Providers (AHIP), USA

Matt Eyles, president and CEO of the Association of Healthcare Insurance Providers (AHIP) outlines how the US health insurance landscape has…

Gerard Anderson
Professor, Johns Hopkins University Bloomberg School of Public Health, USA

Dr Gerard Anderson of Johns Hopkins University Bloomberg School of Public Health critiques the US response to the COVID-19 pandemic, before…

Dan Leonard
President & CEO, Association for Accessible Medicines (AAM)

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities…

Stephen Farr
President & CEO, Zogenix

Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s transition from pain therapeutics into rare diseases, product launch strategies, access and affordability…

Gerard Anderson
Professor, Johns Hopkins University Bloomberg School of Public Health, USA

Dr Gerard Anderson of Johns Hopkins University Bloomberg School of Public Health critiques the US response to the COVID-19 pandemic, before…

Dan Leonard
President & CEO, Association for Accessible Medicines (AAM)

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities…

Stephen Farr
President & CEO, Zogenix

Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s transition from pain therapeutics into rare diseases, product launch strategies, access and affordability…

Christopher Posner
EVP of Region US, LEO Pharma A/S; President & CEO, LEO Pharma Inc.

Christopher Posner, US head for Danish medical dermatology specialist LEO Pharma, outlines how a mid-sized European company navigates the US market’s complex…

Greg Reh
Global Life Sciences & Health Care Leader, Deloitte

Greg Reh leads Deloitte’s global life sciences sector which includes clients in biopharma, medtech, generics and distribution businesses, as well as non-profit patient advocacy organi…

Marc Boutin
CEO, National Health Council, USA

Marc Boutin, JD, CEO of the National Health Council (NHC),* introduces the organization and its mission to provide a united voice for the 160 million people in the US living with chronic diseases and disabilities and their…

Christopher Posner
EVP of Region US, LEO Pharma A/S; President & CEO, LEO Pharma Inc.

Christopher Posner, US head for Danish medical dermatology specialist LEO Pharma, outlines how a mid-sized European company navigates the US market’s complex…

Greg Reh
Global Life Sciences & Health Care Leader, Deloitte

Greg Reh leads Deloitte’s global life sciences sector which includes clients in biopharma, medtech, generics and distribution businesses, as well as non-profit patient advocacy organi…

Marc Boutin
CEO, National Health Council, USA

Marc Boutin, JD, CEO of the National Health Council (NHC),* introduces the organization and its mission to provide a united voice for the 160 million people in the US living with chronic diseases and disabilities and their…

Jorge Alderete
President, ALK Americas & SVP Commercial Operations

Jorge Alderete, president of ALK Americas, outlines the Danish mid-cap’s strategy in the challenging US market, including innovative market access initiatives

William H Lewis
Chairman & CEO, Insmed

William H Lewis, chairman and CEO of serious and rare disease specialist Insmed, talks through the impact of recent product approvals in the US, preparations underway for international launches, the impact…

Robert Matsuk
President, Glenmark North America

Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US – including a manufacturing facility that obtained its first approval in 2019. Matsuk describes the unique busi…

Jorge Alderete
President, ALK Americas & SVP Commercial Operations

Jorge Alderete, president of ALK Americas, outlines the Danish mid-cap’s strategy in the challenging US market, including innovative market access initiatives

William H Lewis
Chairman & CEO, Insmed

William H Lewis, chairman and CEO of serious and rare disease specialist Insmed, talks through the impact of recent product approvals in the US, preparations underway for international launches, the impact…

Robert Matsuk
President, Glenmark North America

Robert Matsuk, president of Glenmark North America, introduces the scope of the company’s operations in the US – including a manufacturing facility that obtained its first approval in 2019. Matsuk describes the unique busi…

Aldo Donati
CEO, IBSA USA

Aldo Donati, CEO for Swiss firm IBSA in the USA, discusses the challenges for European mid-caps in expanding to the US market and his portfolio strategy for ensuring future successes for IBSA USA.

Jose Antonio Moreno Toscano
CEO, LFB USA

Jose Antonio Moreno Toscano, CEO for the US affiliate of iconic French firm LFB shares the company’s journey in the US market and his insights for other European mid-ca…

Brent Ragans
President, Ferring Pharmaceuticals US

Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s operations, their footprint in reproductive health and…

Aldo Donati
CEO, IBSA USA

Aldo Donati, CEO for Swiss firm IBSA in the USA, discusses the challenges for European mid-caps in expanding to the US market and his portfolio strategy for ensuring future successes for IBSA USA.

Jose Antonio Moreno Toscano
CEO, LFB USA

Jose Antonio Moreno Toscano, CEO for the US affiliate of iconic French firm LFB shares the company’s journey in the US market and his insights for other European mid-ca…

Brent Ragans
President, Ferring Pharmaceuticals US

Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s operations, their footprint in reproductive health and…

Michael G. Kauffman
Founder & CEO, Karyopharm TherapeuticsS

Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with…

Bradley Campbell
President & COO, Amicus Therapeutics

Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches, the company’s first steps into the gene therapy space, and how a biotech…

Alper Ureten
VP, General Manager for Biosimilars Business, Amgen

Alper Ureten, Amgen VP and General Manager, sits down with PharmaBoardroom to set out his ambitions and objectives for its Biosimilars Business Unit….

Michael G. Kauffman
Founder & CEO, Karyopharm TherapeuticsS

Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with…

Bradley Campbell
President & COO, Amicus Therapeutics

Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches, the company’s first steps into the gene therapy space, and how a biotech…

Alper Ureten
VP, General Manager for Biosimilars Business, Amgen

Alper Ureten, Amgen VP and General Manager, sits down with PharmaBoardroom to set out his ambitions and objectives for its Biosimilars Business Unit….

Gary Zieziula
President & Region Head North America, Kyowa Kirin

Gary Zieziula, president & region head North America for Kyowa Kirin, a specialty care-focused Japan-based global pharma company, highlights the tremendous growth the affiliate…

Brett Monia
CEO, Ionis Pharmaceuticals

Dr Brett Monia, co-founder and CEO of RNA therapeutics pioneer Ionis Pharmaceuticals, outlines the company’s extremely promising development pipeline, commercial partnerships with Big Pharma…

Joe Lewis
Managing Director, Life Sciences Supply Chain Practice, Deloitte, USA

Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations in the wake of the COVID-19 pandemic…

Gary Zieziula
President & Region Head North America, Kyowa Kirin

Gary Zieziula, president & region head North America for Kyowa Kirin, a specialty care-focused Japan-based global pharma company, highlights the tremendous growth the affiliate…

Brett Monia
CEO, Ionis Pharmaceuticals

Dr Brett Monia, co-founder and CEO of RNA therapeutics pioneer Ionis Pharmaceuticals, outlines the company’s extremely promising development pipeline, commercial partnerships with Big Pharma…

Joe Lewis
Managing Director, Life Sciences Supply Chain Practice, Deloitte, USA

Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations in the wake of the COVID-19 pandemic…

Thanks for reading!

The Digital Version of the Healthcare & Life Science Review: USA is available and optimized for desktop browsers.

Visit our website with your computer or download the pdf report

Read the Full Version

2020. Healthcare & Life Sciences Review was produced by Pharmaboardroom.

Copyright: All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this report, neither PharmaBoardroom nor the authors accept any liabilities forerrors and omissions. Opinions expressed in this report are not necessarily those of the authors. All the images belongs to its respective authors.

Report Director: Lisa Diericks
Senior Editor: Karen Xi, Patrick Burton
Publisher: Diana Viola
Graphic Designer: Miriam León

PharmaBoardroom

Contact us

+44 20 7867 3717 info@pharmaboardroom.com

For media inquiries, please contact: media@pharmaboardroom.com

Address

PharmaBoardroom Limited Lynton House, 7-12, Tavistock Square, London, United Kingdom, WC1H 9LT

Subscribe